- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Milken Institute's Sarah Wells Kocsis Highlights Key Findings of Her Research on CKD
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Sarah Wells Kocsis, MBA, director of the Center for Public Health at the Milken Institute, talks about the key findings of her recently authored report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.”
Transcript
What are the biggest takeaways of your research?
Chronic kidney disease [CKD] is a huge public health problem. It's intricately tied to health equity and social determinants of health. So tackling CKD is going to require a major shift in our mindset and the approach. Roughly 1 in 7 adults have chronic kidney disease, and 9 out of 10 of them don't even know that they have it, so we really need to listen to what the research is telling us. And what it's telling us is that we really need to focus right now on root causes, and these causes are structural, social, and health related. That's going to require practical, scalable, equitable solutions aimed at both detecting and managing the condition upstream at earlier stages and focusing on reducing the burden of this debilitating disease.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
